Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Long-term Investment Intensity
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Long-term Investment Intensity of 5.3% as of September 2019. Long-term investments of CN¥137.76 Million represent 5.3% of total assets of CN¥2.62 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Henan Taloph Pharmaceutical Stock Co Ltd for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Henan Taloph Pharmaceutical Stock Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Henan Taloph Pharmaceutical Stock Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 5.3%, reflecting long-term investments of CN¥137.76 Million against total assets of CN¥2.62 Billion CNY. Also explore Henan Taloph Pharmaceutical Stock Co Ltd total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Henan Taloph Pharmaceutical Stock Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Henan Taloph Pharmaceutical Stock Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 600222 stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 4.9% | CN¥139.77 Million | CN¥2.84 Billion | ▲ +0.7 pp |
| 2017 | 4.3% | CN¥120.05 Million | CN¥2.81 Billion | ▼ -0.3 pp |
| 2016 | 4.5% | CN¥120.18 Million | CN¥2.65 Billion | ▲ +1.7 pp |
| 2015 | 2.9% | CN¥75.68 Million | CN¥2.64 Billion | — |